Table 2.
Characteristic, n (%) | Overall (n=226) |
Invasive ventilation (n=152) |
Noninvasive ventilation (n=74) |
---|---|---|---|
Age, median years (IQR) | 7 (6–8) | 7 (6–8) | 7 (6–12) |
Age started using HMV, median years (IQR) | 3 (2–4) | 3 (2–3) | 3 (2–5) |
HMV usage | |||
>16 hours/day | 177 (78) | 138 (91) | 39 (53) |
<16 hours/day | 49 (22) | 14 (9) | 35 (47) |
Underlying condition | |||
Spinal muscular atrophy type 1 | 61 (27) | 44 (29) | 17 (23) |
Spinal muscular atrophy type 2 | 28 (12) | 12 (8) | 16 (22) |
Muscular dystrophy | 31 (14) | 16 (11) | 15 (20) |
Cerebral palsy | 25 (11) | 19 (13) | 6 (8) |
Hypoventilation (eg, CCHS, obstructive apnea) | 20 (9) | 15 (10) | 5 (7) |
Chronic pulmonary condition | 14 (6) | 9 (6) | 5 (7) |
Thoracic cage abnormality | 10 (4) | 7 (5) | 3 (4) |
Myopathy | 9 (4) | 6 (4) | 3 (4) |
Diaphragm paralysis | 7 (3) | 6 (4) | 1 (1) |
Bronchopulmonary dysplasia | 6 (3) | 5 (3) | 1 (1) |
Other neuromuscular condition | 5 (2) | 4 (3) | 1 (1) |
Congenital heart disease | 4 (2) | 4 (3) | - |
Spina bifida | 2 (1) | 2 (1) | - |
Spinal cord injury | 2 (1) | 2 (1) | - |
Brain injury/mass | 2 (1) | 1 (1) | 1 (1) |
Insurance | |||
Public | 115 (51) | 74 (49) | 41 (55) |
Private | 77 (34) | 68 (45) | 9 (12) |
Public and private | 34 (15) | 10 (7) | 24 (32) |
CCHS, congenital central hypoventilation syndrome; HMV, home mechanical ventilation; IQR, interquartile range